NM_000535.7(PMS2):c.240C>A (p.Phe80Leu) AND Hereditary nonpolyposis colorectal neoplasms

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jul 28, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000690673.10

Allele description [Variation Report for NM_000535.7(PMS2):c.240C>A (p.Phe80Leu)]

NM_000535.7(PMS2):c.240C>A (p.Phe80Leu)

Gene:

PMS2:PMS1 homolog 2, mismatch repair system component [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

7p22.1

Genomic location:

Preferred name:

NM_000535.7(PMS2):c.240C>A (p.Phe80Leu)

HGVS:

NC_000007.14:g.6003982G>T
NG_008466.1:g.10125C>A
NM_000535.7:c.240C>AMANE SELECT
NM_001322003.2:c.-166C>A
NM_001322004.2:c.-166C>A
NM_001322005.2:c.-166C>A
NM_001322006.2:c.240C>A
NM_001322007.2:c.25C>A
NM_001322008.2:c.25C>A
NM_001322009.2:c.-166C>A
NM_001322010.2:c.-166C>A
NM_001322011.2:c.-645C>A
NM_001322012.2:c.-645C>A
NM_001322013.2:c.-166C>A
NM_001322014.2:c.240C>A
NM_001322015.2:c.-245C>A
NP_000526.2:p.Phe80Leu
NP_001308935.1:p.Phe80Leu
NP_001308936.1:p.Arg9=
NP_001308937.1:p.Arg9=
NP_001308943.1:p.Phe80Leu
LRG_161t1:c.240C>A
LRG_161:g.10125C>A
NC_000007.13:g.6043613G>T
NM_000535.5:c.240C>A
NM_000535.6:c.240C>A
NR_136154.1:n.327C>A

Protein change:

F80L

Links:

dbSNP: rs143162541

NCBI 1000 Genomes Browser:

rs143162541

Molecular consequence:

NM_001322003.2:c.-166C>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322004.2:c.-166C>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322005.2:c.-166C>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322009.2:c.-166C>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322010.2:c.-166C>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322011.2:c.-645C>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322012.2:c.-645C>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322013.2:c.-166C>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322015.2:c.-245C>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_000535.7:c.240C>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001322006.2:c.240C>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001322014.2:c.240C>A - missense variant - [Sequence Ontology: SO:0001583]
NR_136154.1:n.327C>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NM_001322007.2:c.25C>A - synonymous variant - [Sequence Ontology: SO:0001819]
NM_001322008.2:c.25C>A - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:: Hereditary nonpolyposis colorectal neoplasms
Identifiers:: MeSH: D003123; MedGen: C0009405

Recent activity

Clear Turn Off Turn On

Pohlia cruda small ribosomal protein 4 (rps4) gene, chloroplast gene encoding ch...
Pohlia cruda small ribosomal protein 4 (rps4) gene, chloroplast gene encoding chloroplast protein, partial cds
gi|3098183|gb|AF023795.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000818372	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Jul 28, 2022)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000818372

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Jul 28, 2022)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000818372.7

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PMS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 492275). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PMS2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 80 of the PMS2 protein (p.Phe80Leu).

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Oct 8, 2024

ClinVar

Relating variation to medicine